Replies to post #136111 on Biotech Values

[biomaven0]

is fibrogen's HIF inhibitor moving very slowly?

Basically they are proceeding like a big pharma rather than a small biotech. That means very large Phase II's in multiple different patient groups - well over 500 patients as of the middle of 2011.

Peter